Ionis Pharmaceuticals Inc (IONS) Stock Forecast & Predictions

Ionis Pharmaceuticals Inc IONS: $37.085

2855 Gazelle Ct, Carlsbad, California, US. | Sector: Manufacturing | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web: www.ionispharma.com

  • Market Cap$5.33B
  • Change (52 Weeks)-35.89%
  • Low (52 Weeks)$34.43
  • Ionis Pharmaceuticals Inc (IONS) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 0.00% are on Buy, 50.00% on Sell, and 50.00% Neutral.

    According to the market data, Ionis Pharmaceuticals Inc (IONS) stock price is $37.085 and the 52 weeks low is $34.43, which means the Ionis Pharmaceuticals Inc stock price is down -35.89% in the last 12 months.

    Ionis Pharmaceuticals Inc (IONS) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 0.00% are indicating that IONS Stock price might rise further, 50.00% indicating that IONS Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall IONS stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Ionis Pharmaceuticals Inc (IONS) Stock Forecast By Analysts


    Strong Buy
    Analysts Recommendations for Ionis Pharmaceuticals Inc (IONS) is based on 25 Institutional Analyst Ratings where 40.00% are on Strong Buy, 16.00% on Moderate Buy, 32.00% remains on Hold, 4.00% are on Moderate Sell and 8.00% are on Strong Sell.

    Out of 25 Institutional Analysts, majority recommended IONS stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Ionis Pharmaceuticals Inc.

    Ionis Pharmaceuticals Inc (IONS) Stock Price Prediction By Analysts


    HighLowAverage
    $119.70$20.20$58.99
    $58.9959.07% Upside
    Updated: 2021-06-18 00:00:00

    The Average Price target for IONS set by the institutional analysts is $58.99 where High Estimate is $119.70, Median $57.120000000000005 and Low $20.20.

    The average price target for IONS by Institutional Analysts is $58.99, which is 59.07% Upside from the current price. So according to the Institutional Analysts, IONS Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Ionis Pharmaceuticals Inc (IONS) Stock Forecast Based on Investor Sentiment


    Very Positive

    Based on 433,085 investor portfolio.

    Our algorithm has analysed 433,085 investor portfolio with IONS stock holdings and found that 99.50% of them are bullish. Which means the Investor Sentiment is mostly Very Positive.

    This shows most investors are very optimistic about IONS and holding their positions hoping for a further rise in the stock price and more profit.

    Ionis Pharmaceuticals Inc (IONS) Stock Forecast Based on News Sentiment


    Neutral
    Based on 1 articles published Last Week, where 50.00% are Bullish and 50.00% are Bearish.

    According to the news articles published last week, journalists and bloggers had a mixed sentiment of IONS consisting of positive and negative, it shows that Ionis Pharmaceuticals Inc had a neutral news coverage.

    Neutral news coverage usually doesn't affect short-term price of a stock, so IONS stock price most likey won't have any reaction to last weeks news coverage.

    Ionis Pharmaceuticals Inc (IONS) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    SVB LeerinkMarket PerformMaintained
    UBSNeutralUpgraded
    Morgan StanleyUnderweightMaintained
    Morgan StanleyUnderweightMaintained
    SVB LeerinkMarket PerformMaintained
    NeedhamBuyMaintained
    Morgan StanleyUnderweightMaintained
    BMO CapitalOutperformMaintained
    Morgan StanleyUnderweightMaintained
    SVB LeerinkMarket PerformMaintained
    Morgan StanleyUnderweightMaintained
    Morgan StanleyUnderweightMaintained
    BenchmarkHoldInitiated
    SVB LeerinkMarket PerformMaintained
    NeedhamBuyMaintained
    CitigroupBuyMaintained
    Morgan StanleyUnderweightMaintained
    Morgan StanleyUnderweightMaintained
    RBC CapitalOutperformInitiated
    OppenheimerOutperformMaintained
    Morgan StanleyUnderweightMaintained
    CitigroupBuyMaintained
    JP MorganNeutralMaintained
    CitigroupBuyInitiated
    Piper SandlerNeutralMaintained
    OppenheimerOutperformInitiated
    William BlairMarket PerformInitiated
    JP MorganNeutralMaintained
    Piper JaffrayNeutralMaintained
    Morgan StanleyUnderweightDowngraded
    Morgan StanleyEqual-WeightMaintained
    Wells FargoOutperformMaintained
    BernsteinOutperformUpgraded
    BMO CapitalOutperformMaintained
    Cantor FitzgeraldNeutralInitiated
    JP MorganNeutralMaintained
    BMO CapitalOutperformMaintained
    Leerink SwannMarket PerformInitiated
    Stifel NicolausHoldMaintained
    Stifel NicolausHoldMaintained
    Morgan StanleyEqual-WeightMaintained
    Stifel NicolausHoldMaintained
    Morgan StanleyEqual-WeightMaintained
    BarclaysUnderweightDowngraded
    Evercore ISI GroupIn-LineDowngraded
    Stifel NicolausHoldMaintained
    Morgan StanleyEqual-WeightMaintained
    BMO CapitalOutperformMaintained
    BMO CapitalOutperformMaintained
    Stifel NicolausHoldMaintained
    BMO CapitalOutperformMaintained
    Morgan StanleyEqual-WeightMaintained
    BMO CapitalOutperformMaintained
    BarclaysEqual-WeightMaintained
    BarclaysEqual-WeightInitiated
    Evercore ISI GroupOutperformInitiated
    BMO CapitalOutperformMaintained
    BernsteinMarket PerformInitiated
    BMO CapitalOutperformMaintained
    Morgan StanleyEqual-WeightMaintained
    Goldman SachsSellDowngraded
    BMO CapitalOutperformUpgraded
    Janney CapitalBuyInitiated
    Morgan StanleyEqual-WeightInitiated
    BarclaysEqual-WeightMaintained
    JP MorganNeutralMaintained
    BMO CapitalMarket PerformDowngraded
    BarclaysEqual-WeightMaintained
    Cowen & Co.Market PerformDowngraded
    Leerink SwannMarket PerformMaintained
    BMO CapitalOutperformInitiated
    JP MorganNeutralMaintained
    BarclaysEqual-WeightMaintained

    Ionis Pharmaceuticals Inc (IONS) Stock Earning Per Share (EPS) Forecast / Estimate


    $-0.406
    The average consensus EPS for IONS is $-0.406 with a high estimate of $-0.252 and Low of $-0.588 for the period 2021-09-30 and based on 19 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $-0.64$-0.53583662021-03-31


    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $$2021-06-30
    $-0.64$-0.53583662021-03-31
    $0.44$0.287833800000000032020-12-31
    $-0.22$-0.0965432020-09-30
    $-0.23$-0.280612200000000032020-06-30
    $-0.35$-0.128785200000000022020-03-31
    $1.41$0.94973222019-12-31
    $0.18$-0.32931722019-09-30
    $-0.01$-0.276083400000000032019-06-30
    $0.62$0.59944380000000012019-03-31
    $0.19$-0.0470732018-12-31
    $-0.03$-0.16598462018-09-30
    $-0.29$-0.091799999999999992018-06-30
    $-0.01$-0.026522018-03-31
    $0.02$0.01445342017-12-31
    $0$-0.05525342017-09-30
    $-0.09$-0.04082017-06-30
    $0.03$0.055082017-03-31
    $0.24$-0.11900342016-12-31
    $0.06$0.07820342016-09-30
    $-0.47$-0.54144662016-06-30
    $-0.52$-0.512016-03-31
    $-0.59$-0.4942412015-12-31
    $-0.3$-0.31506782015-09-30
    $0.29$0.29353562015-06-30
    $-0.14$-0.205132200000000012015-03-31
    $0.16$0.01587122014-12-31
    $-0.23$-0.209099999999999982014-09-30
    $-0.1$-0.13712882014-06-30
    $-0.27$-0.241739999999999982014-03-31
    $-0.21$-0.173400000000000032013-12-31
    $-0.21$-0.275400000000000032013-09-30
    $-0.09$-0.21080342013-06-30
    $-0.03$-0.02492882013-03-31
    $-0.23$-0.23007122012-12-31
    $-0.33$-0.26859662012-09-30
    $-0.01$-0.097471200000000012012-06-30
    $-0.24$-0.263924999999999972012-03-31
    $-0.2$-0.181052011-12-31
    $-0.27$-0.21080342011-09-30

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).